Hepatectomy
ProcedureSurgery for liver tumors is the removal of a part of the liver affected by a tumor.
Other names: hepatic resection; liver resection; liver surgery
NCT Number: NCT03171428
The performance of hepatectomy for liver tumors using the thoraco-abdominal approach (TAA) versus the abdominal approach (AA) is still debated.
The aim of the study is the analysis of the perioperative outcome of patients operated with or without the TAA for liver tumors.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The prospectively maintained database was queried. A 1:1 propensity score-matched analysis was applied. Among 744 patients, 246 undergoing hepatectomy with TAA and 246 undergoing hepatectomy with AA were compared. These patients were matched for baseline characteristics, underlying liver disease, comorbidity, tumor features, and extent of the resection. The rates of morbidity and mortality were the study endpoints.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgery for liver tumors is the removal of a part of the liver affected by a tumor.
Other names: hepatic resection; liver resection; liver surgery
Time frame: Within 90-days after the operation
Occurrence of postoperative complications or death after surgery
University of Milan
Other
Hepatectomy With or Without the Thoraco-abdominal Approach: Impact on Perioperative Outcome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05261113
Adenocarcinoma, Carcinoma
Regensburg, Germany
View Trial DetailsNCT04820712
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial DetailsNCT03178409
Adenocarcinoma, Carcinoma
View Trial DetailsNCT06929845
Adenocarcinoma, Carcinoma
Roma, Italy
View Trial Details